U.S. FDA authorizes Merck’s at-home antiviral COVID-19 pill
December 23, 2021 (Reuters) – The U.S. on Thursday authorized Merck & Co’s (MRK.N) antiviral pill for COVID-19 for certain high-risk adult patients, a…
December 23, 2021 (Reuters) – The U.S. on Thursday authorized Merck & Co’s (MRK.N) antiviral pill for COVID-19 for certain high-risk adult patients, a…
Recent lab data suggests the Pfizer antiviral Covid pill retains its effectiveness against the fast spreading Omicron variant. NEW YORK, Dec 14,…
MEXICO, (November 19, 2021).- Mexico and Israel, through the Israeli pharmaceutical company Oramed, announced an agreement with the Mexican Genomma Lab, for…
Almost 1 million children ages 5 to 11 have received their first COVID-19 shot within the first week of eligibility, the Biden…